Cargando…

Screening and Identification of Potential Prognostic Biomarkers in Adrenocortical Carcinoma

Objective: Adrenocortical carcinoma (ACC) is a rare but aggressive malignant cancer that has been attracting growing attention over recent decades. This study aims to integrate protein interaction networks with gene expression profiles to identify potential biomarkers with prognostic value in silico...

Descripción completa

Detalles Bibliográficos
Autores principales:	Xu, Wen-Hao, Wu, Junlong, Wang, Jun, Wan, Fang-Ning, Wang, Hong-Kai, Cao, Da-Long, Qu, Yuan-Yuan, Zhang, Hai-Liang, Ye, Ding-Wei
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2019
Materias:	Genetics
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6749084/ https://www.ncbi.nlm.nih.gov/pubmed/31572440 http://dx.doi.org/10.3389/fgene.2019.00821

Ejemplares similares

Construction of a robust prognostic model for adult adrenocortical carcinoma: Results from bioinformatics and real‐world data
por: Tian, Xi, et al.
Publicado: (2021)

Alternative Splicing Events and Splicing Factors Are Prognostic in Adrenocortical Carcinoma
por: Lv, Jian, et al.
Publicado: (2020)

Co-expression Network Analysis of Biomarkers for Adrenocortical Carcinoma
por: Yuan, Lushun, et al.
Publicado: (2018)

Identification of a ferroptosis-related long noncoding RNA signature with a prognostic value in adrenocortical carcinoma
por: Wang, Weixi, et al.
Publicado: (2022)

Identification of a chromatin regulator signature and potential prognostic ability for adrenocortical carcinoma
por: Li, Junwu, et al.
Publicado: (2022)

Identification of prognostic biomarkers in papillary renal cell carcinoma and PTTG1 may serve as a biomarker for predicting immunotherapy response
por: Tian, Xi, et al.
Publicado: (2022)

Identification and validation of novel prognostic biomarkers and therapeutic targets for non-small cell lung cancer
por: Lai, Li-Ting, et al.
Publicado: (2023)

Identification of GGT5 as a Novel Prognostic Biomarker for Gastric Cancer and its Correlation With Immune Cell Infiltration
por: Wang, Yuli, et al.
Publicado: (2022)

The Role of Serine Peptidase Inhibitor Kazal Type 13 (SPINK13) as a Clinicopathological and Prognostic Biomarker in Patients with Clear Cell Renal Cell Carcinoma
por: Xu, Wen-Hao, et al.
Publicado: (2019)

Identification of Tumor Microenvironment-Related Prognostic Biomarkers in Luminal Breast Cancer
por: Wang, Yanyan, et al.
Publicado: (2020)

Prognostic value and immune infiltration of novel signatures in clear cell renal cell carcinoma microenvironment
por: Xu, Wen-Hao, et al.
Publicado: (2019)

Identification of Potential Prognostic Biomarkers Associated With Cancerometastasis in Skin Cutaneous Melanoma
por: Li, Yang, et al.
Publicado: (2021)

Screening and identification of key biomarkers in adrenocortical carcinoma based on bioinformatics analysis
por: Xing, Zengmiao, et al.
Publicado: (2019)

Procollagen-lysine, 2-oxoglutarate 5-dioxygenases 1, 2, and 3 are potential prognostic indicators in patients with clear cell renal cell carcinoma
por: Xu, Wen-Hao, et al.
Publicado: (2019)

Identification of pyroptosis-related subtypes, development of a prognostic model, and characterization of tumour microenvironment infiltration in gastric cancer
por: Cao, Feng, et al.
Publicado: (2022)

Bioinformatic screening and identification of downregulated hub genes in adrenocortical carcinoma
por: Xu, Fangshi, et al.
Publicado: (2020)

Identification of Potential Diagnostic and Prognostic Biomarkers for Colorectal Cancer Based on GEO and TCGA Databases
por: Wang, Zhenjiang, et al.
Publicado: (2021)

Liver and Kidney Function Biomarkers, Blood Cell Traits and Risk of Severe COVID-19: A Mendelian Randomization Study
por: Wang, Kai, et al.
Publicado: (2021)

Screening and Identification of Potential Biomarkers in Hepatitis B Virus-Related Hepatocellular Carcinoma by Bioinformatics Analysis
por: Zeng, Xian-Chang, et al.
Publicado: (2020)

Identification of Potential Prognostic Genes for Neuroblastoma
por: Zhong, Xiaodan, et al.
Publicado: (2018)

Hypermethylation of N-Acetyltransferase 1 Is a Prognostic Biomarker in Colon Adenocarcinoma
por: Shi, Cheng, et al.
Publicado: (2019)

Identification of prognostic and therapeutic biomarkers in type 2 papillary renal cell carcinoma
por: Wang, Yue, et al.
Publicado: (2023)

Identification of IGF2BP3 as an Adverse Prognostic Biomarker of Gliomas
por: Sun, Chao, et al.
Publicado: (2021)

Identification of Novel Prognostic Biomarkers Relevant to Immune Infiltration in Lung Adenocarcinoma
por: Xia, Zhi, et al.
Publicado: (2022)

Identification of novel prognostic biomarkers in the TF-enhancer-target regulatory network in hepatocellular carcinoma and immune infiltration analysis
por: Yan, Jianing, et al.
Publicado: (2023)

Chaperonin-Containing TCP1 Subunit 6A Is a Prognostic Potential Biomarker That Correlates With the Presence of Immune Infiltrates in Colorectal Cancer
por: Sun, Hui, et al.
Publicado: (2021)

The prognosis difference between elderly and younger patients with adrenocortical carcinoma
por: He, Shengyin, et al.
Publicado: (2023)

Identification and Validation of Chromobox Family Members as Potential Prognostic Biomarkers and Therapeutic Targets for Human Esophageal Cancer
por: Fang, Xuefen, et al.
Publicado: (2022)

Identification of Enhancer RNA CDK6-AS1 as a Potential Novel Prognostic Biomarker in Gastric Cancer
por: Yang, Shifeng, et al.
Publicado: (2022)

Identification of Potential Diagnostic and Prognostic Biomarkers for Gastric Cancer Based on Bioinformatic Analysis
por: Niu, Xiaoji, et al.
Publicado: (2022)

Identification of Extracellular Matrix Signatures as Novel Potential Prognostic Biomarkers in Lung Adenocarcinoma
por: Zeng, Zhen, et al.
Publicado: (2022)

Identification and Verification of Immune-Related Genes Prognostic Signature Based on ssGSEA for Adrenocortical Carcinoma (ACC)
por: Yuan, Kaisheng, et al.
Publicado: (2022)

Identification of CD161 expression as a novel prognostic biomarker in breast cancer correlated with immune infiltration
por: Weng, Miaomiao, et al.
Publicado: (2022)

EFNA3 Is a Prognostic Biomarker Correlated With Immune Cell Infiltration and Immune Checkpoints in Gastric Cancer
por: Zheng, Peng, et al.
Publicado: (2022)

KRAS is a prognostic biomarker associated with diagnosis and treatment in multiple cancers
por: Zhao, Da, et al.
Publicado: (2022)

Identifying Differential Expression Genes and Prognostic Signature Based on Subventricular Zone Involved Glioblastoma
por: Yuan, Qing, et al.
Publicado: (2022)

Identification of prognostic biomarkers in the CMTM family genes of human ovarian cancer through bioinformatics analysis and experimental verification
por: Zhang, Mengjun, et al.
Publicado: (2022)

Identification of Candidate Biomarkers for Salt Sensitivity of Blood Pressure by Integrated Bioinformatics Analysis
por: Chen, Chen, et al.
Publicado: (2020)

Identification and Validation of an Immunological Expression-Based Prognostic Signature in Breast Cancer
por: Pei, Jianying, et al.
Publicado: (2020)

Identification of Prognostic Biomarkers and Correlation With Immune Infiltrates in Hepatocellular Carcinoma Based on a Competing Endogenous RNA Network
por: Pu, Zhangya, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_4idf11si11640g863akg5cr1l3